피나스테리드 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 제형별, 유효 성분 농도별, 용도별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Finasteride Market size was valued at USD 102.6 Million in 2024 and is poised to grow from USD 105.14 Million in 2025 to USD 127.91 Million by 2033, growing at a CAGR of 2.48% during the forecast period (2026-2033).

The global finasteride market is significantly influenced by the increasing clinical demand for treating androgenetic alopecia and benign prostatic hyperplasia, fostering a substantial, long-lasting patient base. This market includes both branded and generic oral formulations that provide essential hair restoration and symptom relief for prostate concerns. These treatments enhance quality of life and generate a consistent revenue stream for healthcare providers and manufacturers. The rise of generics has made therapy more accessible and cost-effective, fueling widespread adoption and expanding market penetration. Additionally, advancements in AI-driven demand forecasting enhance the ability to adapt to evolving market dynamics, optimize production, and improve distribution strategies, thereby ensuring efficient inventory management and better patient access to both oral and emerging topical treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Finasteride market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Finasteride Market Segments Analysis

Global finasteride market is segmented by product type, dosage form, strength, application, distribution channel, end user and region. Based on product type, the market is segmented into Branded Finasteride, Generic Finasteride and Others. Based on dosage form, the market is segmented into Tablets, Oral Solutions and Others. Based on strength, the market is segmented into 1 mg, 5 mg and Others. Based on application, the market is segmented into Androgenetic Alopecia (Male Pattern Baldness), Benign Prostatic Hyperplasia (BPH) and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics, Homecare Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Finasteride Market

The global demand for finasteride is rising due to the growing awareness of male pattern hair loss and the increasing number of patients seeking effective medical treatments. Its ability to act on hormonal pathways provides a perceived long-term solution, prompting healthcare providers to advocate for its use. Enhanced diagnostic methods and earlier patient engagement facilitate the initiation of treatment, while improved patient education regarding its effectiveness and tolerability promotes ongoing usage. This favorable therapeutic perception leads to consistent prescribing habits and greater real-world application, thereby enhancing product adoption within primary care and dermatological practices, further extending the market's reach.

Restraints in the Global Finasteride Market

The global finasteride market faces significant constraints due to the perceived and reported adverse effects associated with its use, which foster caution among both patients and healthcare providers. Concerns surrounding issues such as sexual dysfunction and other potential long-term impacts lead clinicians to engage in extensive discussions about the associated risks. This often causes patients to lean towards alternative treatments or postpone initiating therapy altogether. The heightened need for thorough counseling and follow-up increases the clinical workload and may result in clinicians prescribing finasteride primarily to patients with clear clinical necessities. Consequently, this safety-related apprehension limits market penetration and impedes the widespread adoption of finasteride as a primary treatment option.

Market Trends of the Global Finasteride Market

The Global Finasteride market is witnessing significant growth, driven by increased healthcare access and heightened consumer awareness in emerging markets. Companies are strategically forming local partnerships and enhancing their distribution networks to cater to diverse regional needs, while patient education initiatives are being tailored to align with cultural preferences. The rise of telemedicine and digital pharmacies has further improved access to treatments in previously underserved areas, alongside efforts for localized production to enhance affordability. Additionally, engaging with healthcare professionals like dermatologists and primary care providers is fostering greater adoption, establishing new, sustainable channels for long-term market expansion beyond established geographies.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Finasteride Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Branded Finasteride
• Generic Finasteride
• Others

Global Finasteride Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets
• Oral Solutions
• Others

Global Finasteride Market Size by Strength & CAGR (2026-2033)

• Market Overview
• 1 mg
• 5 mg
• Others

Global Finasteride Market Size by Application & CAGR (2026-2033)

• Market Overview
• Androgenetic Alopecia (Male Pattern Baldness)
• Benign Prostatic Hyperplasia (BPH)
• Others

Global Finasteride Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Finasteride Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare Settings
• Others

Global Finasteride Market Size & CAGR (2026-2033)

• North America (Product Type, Dosage Form, Strength, Application, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Dosage Form, Strength, Application, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dosage Form, Strength, Application, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dosage Form, Strength, Application, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dosage Form, Strength, Application, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alkem Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apotex Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations